P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2021; 5(3): 222-227 | DOI: 10.14744/ejmo.2021.19181

Impact of Gender on the Prognosis of Patients with Hepatocellular Carcinoma After Palliative Therapy

Lei Liu1, Hao-Tian Liu2, Xiu-Mei Liang2, Xu Liu2, Zhu-Jian Deng2, Liang Ma2, Bang-De Xiang2, De-Jia Huang3, Jian-Hong Zhong2
1Department of Hepatobiliary Surgery, Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China, 2Department of Hepatobiliary Surgery, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China, 3Department of Interventional Surgery, Guangxi Medical University Cancer Hospital, Nanning, China,

Objectives: Sex differences are ascribed to the risk of hepatocellular carcinoma (HCC); however, whether gender disparity also exists in the prognosis of palliative therapy is yet unclear. A retrospective cohort study was performed to assess the prognostic predictors after palliative therapy of HCC, focusing on sex differences. Methods: This retrospective cohort study consisted of 2356 patients (270 women and 2086 men) with a diagnosis of HCC between 2006 and 2011. The patients received palliative care. Clinical and laboratory data were evaluated and compared. Results: Overall, the two groups did not have significant sex-related differences in prognosis for overall survival (OS) of palliative care, including transarterial chemoembolization (TACE), chemotherapy, and best supportive care (BSC). Using multivariate analysis, the following were identified as independent risk factors of survival (P<0.05): smoking, liver cirrhosis, vascular invasions, tumor size, absolute value of neutrophils, and glutamyltransferase. Transarterial chemoembolization was regarded as protective factor of OS. Conclusion: No significant differences were observed in the prognosis of male or female HCC patients after palliative care. The gender factor was not an independent predictor for OS. Keywords: Gender, hepatocellular carcinoma, palliative care, prognosis, overall survival Address for correspondence: Lei Liu, Hao-Tian Liu and Xiu-Mei Liang, MD. Guangxi Medical University Cancer Hospital, He Di Rd #71, Nanning 530021, China

Cite This Article

Liu L, Liu H, Liang X, Liu X, Deng Z, Ma L, et al. Impact of Gender on the Prognosis of Patients with Hepatocellular Carcinoma After Palliative Therapy. EJMO. 2021; 5(3): 222-227

Corresponding Author: Lei Liu

Full Text PDF PDF Download